April McClain Delaney
Trade Performance Intelligence
Score: 4/10Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsApril McClain Delaney bought $1,001 - $15,000 in $LH (Labcorp Holdings Inc. Common Stock) on October 31, 2025, 32 days before the Kidd’s Stuttering Act (HR6364) was introduced, a bill mandating Medicaid and CHIP coverage for childhood-onset fluency disorder screenings.
April McClain Delaney bought $1,001 - $15,000 in $LH (Labcorp Holdings Inc. Common Stock) on October 31, 2025, 33 days before the ANCHOR Act of 2025 (HR6408) was introduced, which expands Medicaid eligibility for individuals with serious mental illness or substance use disorder.
April McClain Delaney bought $1,001 - $15,000 in $LH (Labcorp Holdings Inc. Common Stock) on October 31, 2025, 39 days before the Ensuring Excellence in Mental Health Act (S3402) was introduced, a bill expanding Medicare and Medicaid coverage for certified community behavioral health clinics.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $NDAQ | Nasdaq, Inc. - Common Stock | $15K-$50K | — | — | — | Oct 22, 2025 |
| BUY | $TECH | Bio-Techne Corp - Common Stock | $1K-$15K | — | — | — | Oct 22, 2025 |
| BUY | $BJ | BJ's Wholesale Club Holdings, Inc. Common Stock | $1K-$15K | — | — | — | Oct 16, 2025 |
| BUY | $BJ | BJ's Wholesale Club Holdings, Inc. Common Stock | $1K-$15K | — | — | — | Oct 15, 2025 |
| BUY | $BRO | Brown & Brown, Inc. Common Stock | $1K-$15K | — | — | — | Oct 29, 2025 |
| BUY | $BRO | Brown & Brown, Inc. Common Stock | $1K-$15K | — | — | — | Oct 31, 2025 |
| BUY | $LH | Labcorp Holdings Inc. Common Stock | $1K-$15K | — | — | — | Oct 29, 2025 |
| BUY | $LH | Labcorp Holdings Inc. Common Stock | $1K-$15K | — | — | — | Oct 31, 2025 |
| BUY | $NDAQ | Nasdaq, Inc. - Common Stock | $1K-$15K | — | — | — | Oct 9, 2025 |
| BUY | $PAYX | Paychex, Inc. - Common Stock | $1K-$15K | — | — | — | Oct 1, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Kid PROOF Act of 2025
The Kid PROOF Act of 2025, HR6396, is in early legislative stages, having been referred to two committees. This bill expands the use of existing SUPPORT Act grants for pediatric and young adult suicide and overdose prevention, but does not authorize new funding. Recent market data shows mixed performance among healthcare companies, with $CNC and $MOH showing positive 7-day changes, while $UHS and $HCA also show positive 7-day changes, and $LH shows a positive 7-day change.
Repealing the IMD Exclusion Act
The Repealing the IMD Exclusion Act removes federal Medicaid payment prohibitions for mental health and substance use disorder services in larger facilities for individuals under 65. This expands the addressable market for mental health and substance use disorder treatment providers, directly increasing their revenue potential from Medicaid patients.
Thyroid Disease CARE Act of 2025
The Thyroid Disease CARE Act of 2025 authorizes $30 million annually for five years for thyroid disease research, improving diagnostics, and treatment. This directly benefits companies involved in medical diagnostics, research tools, and pharmaceutical development for thyroid conditions. The bill's referral to the House Committee on Energy and Commerce indicates a standard legislative path.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025
This bill expands Medicare coverage for cardiac and pulmonary rehabilitation, allowing physician assistants, nurse practitioners, and clinical nurse specialists to administer these services. This directly increases the addressable market for rehabilitation providers and medical staffing agencies. The change is effective immediately upon enactment.
Kidd’s Stuttering Act
The Kidd's Stuttering Act (HR6364), currently in committee, mandates Medicaid and CHIP coverage for childhood-onset fluency disorder screenings and speech therapy. This bill would create a new, guaranteed revenue stream for diagnostic and therapy providers and expand the market for speech-language pathology services, impacting health insurers and diagnostic companies. While no direct funding is specified, it would increase demand for services.
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
HR3383 removes SEC restrictions on closed-end funds investing in private funds, directly increasing capital access for private equity firms. This bill expands investment avenues for closed-end funds and creates new listing opportunities for national securities exchanges. Private equity firms and exchange operators are direct beneficiaries.
BRAVE Act of 2025
The BRAVE Act of 2025, currently in the early committee stage, aims to expand VA mental health services. While it authorizes policy changes and program extensions, it does not explicitly appropriate new funding, meaning direct revenue opportunities for healthcare providers are not yet guaranteed. The bill's focus on mental health and veteran services could structurally benefit companies with existing or potential VA contracts if it progresses and secures appropriations.
Employee Profit-Sharing Encouragement Act of 2025
The Employee Profit-Sharing Encouragement Act of 2025 (HR6418) has been introduced in the House and referred to the Committee on Ways and Means. This bill, if enacted, would mandate profit-sharing for companies deducting executive compensation, potentially increasing demand for HR and payroll software and boosting consumer spending. The bill is currently in an early legislative stage.
ANCHOR Act of 2025
The ANCHOR Act of 2025 expands Medicaid eligibility to uninsured individuals with serious mental illness or substance use disorder, increasing the addressable market for healthcare providers and insurers. This bill establishes a state option for medical assistance, directly benefiting companies involved in behavioral health services and Medicaid managed care. The expansion of covered services will drive revenue growth for diagnostic and staffing companies.
Ensuring Excellence in Mental Health Act
The Ensuring Excellence in Mental Health Act expands Medicare and Medicaid coverage for certified community behavioral health clinics (CCBHCs), creating a new revenue stream for mental health service providers. This legislation establishes a prospective payment system for CCBHCs under Medicaid and introduces Medicare coverage, directly increasing demand and funding for these services. Companies involved in healthcare administration, behavioral health services, and diagnostic testing will see increased utilization and revenue.
Live Charts
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.